Optimizing Outcomes: Making the Early Diagnosis of Rheumatoid Arthritis in Primary Care

Title:

Optimizing Outcomes: Making the Early Diagnosis of Rheumatoid Arthritis in Primary Care

Topic: Rheumatology
Relevant Terms: Rheumatoid Arthritis
Primary Audience: Primary Care Practitioners
Launch Date: 16-Feb-11
Credits: 0.5 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Early Diagnosis RA in Primary Care

Learning Objectives

Upon completion of the activity, participants should be able to:

  1. Identify patients who have probable early rheumatoid arthritis (RA) and should be referred to a rheumatologist
  2. Incorporate simple screening techniques for RA into daily practice
  3. Employ the squeeze test to assist with diagnosis of RA
  4. Order appropriate laboratory tests when RA is suspected
  5. Order proper vaccinations for patients starting disease-modifying antirheumatic drug (DMARD) therapy

    Faculty

    Steering Committee
    Karen H. Costenbader, MD, MPH—Activity Leader
    Associate Physician
    Division of Rheumatology, Immunology and Allergy
    Brigham and Women's Hospital
    Assistant Professor of Medicine
    Harvard Medical School
    Boston, Massachusetts
    Paul P. Doghramji, MD, FAAFP—Activity Leader
    Medical Director for Health Services at Ursinus College
    Family Physician, Collegeville Family Practice
    Collegeville, Pennsylvania
    Michael E. Weinblatt, MD—Steering Committee Co-Chair
    John R. and Eileen K. Riedman Professor of Medicine
    Harvard Medical School
    Co-Director, Clinical Rheumatology
    Division of Rheumatology, Immunology and Allergy
    Brigham and Women's Hospital
    Boston, Massachusetts
    Lauren G. Collins, MD—Steering Committee Co-Chair
    Assistant Professor of Family and Community Medicine
    Jefferson Medical College of Thomas Jefferson University
    Philadelphia, Pennsylvania
    Clifton O. Bingham III, MD
    Associate Professor of Medicine
    Divisions of Rheumatology and Allergy and Clinical Rheumatology
    Director, Johns Hopkins Arthritis Center
    Director, Rheumatology Clinics
    Johns Hopkins University
    Baltimore, Maryland
    Joyce P. Carlone, MN, RN, FNP-BC, CCRC
    Nurse Practitioner, Division of Rheumatology
    Emory University
    Atlanta, Georgia
    Mary Suzanne Cleveland, JD (Patient/Patient Educator)
    Senior Analyst
    Kansas Health Institute
    Topeka, Kansas
    David S. Kountz, MD, MBA, FACP
    Senior Vice President, Medical and Academic Affairs
    Jersey Shore University Medical Center
    Associate Professor of Medicine
    Robert Wood Johnson Medical School
    New Brunswick, New Jersey
    Optimizing Outcomes: Making the Early Diagnosis of Rheumatoid Arthritis in Primary Care

    Release date:  February 16, 2011
    Expiration date: February 16, 2012
    Estimated time to complete activity: 0.5 hours

    Co-sponsored by Curatio CME Institute and Jefferson Medical College of Thomas Jefferson University.

    Support for this activity has been provided through educational grants from Abbott, Centocor Ortho Biotech Inc., and Pfizer.

    Activity Overview
    Rheumatoid arthritis (RA) is a chronic, progressive, systemic inflammatory disease characterized by progressive destruction of synovial joints and loss of cartilage and bone. This ClinicalUpdate discusses the early diagnosis of RA in primary care, and the clinical management of RA patients before they are seen by a rheumatologist. Topics include the importance of an early and accurate provisional diagnosis, targeted laboratory screening methods, the benefits of a multidisciplinary team approach, and the potential benefit of early intervention on the course and prognosis of RA.

    Target Audience
    This activity has been designed to meet the educational needs of primary care providers.

    Accreditation Statement
    This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). Jefferson Medical College of Thomas Jefferson University is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation
    Jefferson Medical College of Thomas Jefferson University designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Method of Participation
    There are no fees for participating in this CME activity. To receive credit during the period February 16, 2011 to February 16, 2012, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the posttest and activity evaluation form, including the certificate information section.

    To obtain a certificate of participation on the Real CME site, participants must receive a score of 75% or better on the posttest. The posttest can be accessed at the end of the activity.
    Those who successfully complete the activity can retrieve their official CME certificate using Jefferson's online access at http://jeffline.jefferson.edu/jeffcme/RAPID.
    Please e-mail any questions to jeffersoncme@jefferson.edu or call us at 888 JEFF CME.

    Medium
    The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.

    Disclosure
    Jefferson Medical College of Thomas Jefferson University endorses the Standards of the ACCME and the Guidelines for Commercial Support. Every effort has been made to encourage faculty to disclose any commercial relationships or personal benefit with commercial companies whose products may be discussed in this educational tool. Disclosure of a relationship is not intended to suggest or condone bias in any presentations, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
     
    Relationship information appears below:
    The following individuals have declared financial interests and/or affiliations:
    Clifton O. Bingham III, MD:
    Grant/Research Support: BMS, Genentech, UCB, Roche
    Consultant: Genentech, Roche, Centocor Ortho Biotech, Merck, UCB, Flexion, Celgene
    Joyce P. Carlone, MN, RN, FNP-BC, CCRC:
    Consultant: UCB
    Product/Speakers Bureau: UCB
    Other: UCB
    David S. Kountz, MD, MBA, FACP:
    Consultant: NiCox, Novartis
    Michael E. Weinblatt, MD:
    Grant/Research Support: Abbott
    Consultant: Abbott, Centocor Ortho Biotech, Pfizer/Wyeth

    The following individuals have declared no financial interests and/or affiliations:
    Mary Suzanne Cleveland, JD
    Lauren G. Collins, MD
    Karen H. Costenbader, MD, MPH
    Paul P. Doghramji, MD, FAAFP

     
    Jefferson Medical College of Thomas Jefferson University
    Jeanne G. Cole, Ed D, FACME, Director, Office of CME, has disclosed no relevant financial relationships.

    Curatio CME Institute
    Daniel Duch, PhD, Medical Director, has disclosed no relevant financial relationships.
    Jonathan S. Simmons, ELS, Managing Editor, has disclosed no relevant financial relationships.
     
    Disclaimer
    The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient's medical condition.

    Unapproved Product Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Jefferson Medical College of Thomas Jefferson University, Curatio CME Institute, Abbott, Centocor Ortho Biotech Inc., and Pfizer do not recommend the use of any agent outside the labeled indications. When a pharmaceutical agent is discussed outside of labeling, it is identified with an (*).

    The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Jefferson Medical College of Thomas Jefferson University, Curatio CME Institute, Abbott, Centocor Ortho Biotech Inc., and Pfizer. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy Statement
    This statement explains the privacy policy of internet activities on the Web site of Jefferson Medical College Office of Continuing Medical Education.
    • For each visitor to our Web page, our Web server automatically recognizes only the consumer's domain name.
    • We collect aggregate information on what pages are visited in order to assess and improve the content of our site.
    • We do not set any "cookies" to track visitor's identification or use of the site.
    • The information we collect is not shared with other organizations for commercial purposes.
    • We have appropriate security measures in place in our physical facilities to protect against the loss, misuse or alteration of information that we have collected from you at our site.
    • Upon request, we will provide site visitors with access to all information that we maintain about them.
    • If our information practices change at some time in the future, we will post the policy changes to our Web site to notify you of these changes.
    • If you feel that this site is not following its stated information policy, you may contact us at: jeffersoncme@jefferson.edu or 888 JEFF CME.